Axinix, a prescription medication, is designed to combat advanced renal cell carcinoma (RCC) by inhibiting tumor growth through the blockage of proangiogenic cytokines like vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor (PDGF). Axitinib, the active ingredient, is manufactured by Beacon Pharma Ltd. in Bangladesh and is available in 1 mg and 5 mg tablet formulations. This medication is designed for convenient oral consumption and can be taken with or without food, twice daily. Axitinib effectively inhibits tumor growth by targeting VEGF and PDGF cytokines, which are involved in the development of blood vessels that feed tumors. The medication is available in 180's Pot and 60's Pot pack sizes. For morecheck here